|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Eslicarbazepine
Test Code92139
CPT Codes
80299
Preferred Specimen
1 mL serum collected in a red-top tube (no gel)
Minimum Volume
0.5 mL
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 5 days
Refrigerated: 14 days
Frozen: 31 days
Refrigerated: 14 days
Frozen: 31 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Serum separator tubes (SST®)
Methodology
Chromatography/Mass Spectrometry
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Tues, Thurs, Sat a.m.; Report available: 5-7 days
Reference Range
No established therapeutic range; individual patient concentrations should be evaluated in context of patient's clinical condition or prior concentration.
Trough plasma levels following doses of 400-2400 mg/day, averaged 2-28 mcg/mL. Maximum plasma concentrations following 2400 mg/day dosages averaged 55 mcg/mL.
Trough plasma levels following doses of 400-2400 mg/day, averaged 2-28 mcg/mL. Maximum plasma concentrations following 2400 mg/day dosages averaged 55 mcg/mL.
Clinical Significance
Monitoring eslicarbazepine is helpful to avoid toxicity and to use as a baseline for future therapy. There is no established reference range. Individual patient concentrations should be evaluated in context of patient's clinical condition and prior concentrations.
